Press release
Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach US$ 21.48 Bn by 2031
Worldwide sales of psoriasis drugs amounted to around US$ 11.37 Bn in 2021. The global psoriasis drugs market is predicted to progress at a CAGR of 6.5% to reach a valuation of US$ 21.48 Bn by 2031.
Need More Insights on Competitor Analysis of the Psoriasis Drugs Market, Request for Sample@ https://www.persistencemarketresearch.com/samples/25102
The psoriasis drugs market can be segmented based on drug class, route of administration, and distribution channel. The drug class segment includes corticosteroids, immunosuppressants, biologics, and others. The route of administration segment includes topical, oral, and injectable. The distribution channel segment includes hospital pharmacies, retail pharmacies, and online pharmacies.
Companies
Janssen Biotech, Inc.
Novartis International Ltd.
Amgen Inc
Pfizer Inc.
Takeda Pharmaceutical Company Ltd.
Merck & Co, Inc.
Abb Vie Inc.
Eli Lilly and Company
Boehringer Ingelheim GmbH
Sun Pharmaceutical Industries Ltd
If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/25102
Biologics are the largest segment of the psoriasis drugs market, accounting for the majority of the revenue. Biologics are a class of drugs that target specific proteins in the immune system that are responsible for the inflammation and rapid skin cell growth associated with psoriasis. Biologics are highly effective in treating psoriasis, but they are also expensive and can have significant side effects.
Topical treatments, such as corticosteroids and retinoids, are also commonly used in the treatment of psoriasis. These treatments are less expensive than biologics and are generally well-tolerated, but they may not be as effective in treating severe cases of psoriasis.
The psoriasis drugs market is also being driven by the increasing availability of biosimilars, which are lower-cost versions of biologic drugs that have similar efficacy and safety profiles. Biosimilars are expected to play a significant role in the psoriasis drugs market in the coming years, particularly in developing countries where access to expensive biologics is limited.
The psoriasis drugs market faces several challenges, including the high cost of biologics and the potential for significant side effects. In addition, there is a need for more effective treatments for severe cases of psoriasis, as well as for treatments that target the underlying causes of the disease rather than just the symptoms.
If you want to Purchase Specific Insights by Segment/Region/Competitor, Request For Customization @ https://www.persistencemarketresearch.com/request-customization/25102
Key Segments Covered in Psoriasis Drugs Industry Research
Psoriasis Drugs Market by Product:
Topical Psoriasis Drugs
Oral Psoriasis Drugs
Injectable Psoriasis Drugs
Psoriasis Drugs Market by Drug Class:
Interleukin Inhibitors
Corticosteroids
Anti-inflammatory
Tumor Necrosis Factor Inhibitors
Psoriasis Drugs Market by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
e-Commerce
Psoriasis Drugs Market by Indication:
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
Erythrodermic Psoriasis
Plaque Psoriasis
Psoriasis Drugs Market by Region:
North America Psoriasis Drugs Market
Latin America Psoriasis Drugs Market
Europe Psoriasis Drugs Market
South Asia Psoriasis Drugs Market
East Asia Psoriasis Drugs Market
Oceania Psoriasis Drugs Market
Middle East and Africa (MEA) Psoriasis Drugs Market
Top Market Research Reports:
Growth Factors Market: https://www.persistencemarketresearch.com/market-research/growth-factors-market.asp
Botulinum Toxin Market: https://www.persistencemarketresearch.com/market-research/botulinum-toxin-market.asp
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Drugs Market is predicted to progress at a CAGR of 6.5% to reach US$ 21.48 Bn by 2031 here
News-ID: 3047664 • Views: …
More Releases from Persistence Market Research
Libya Baby Diapers and Wipes Market Set to Reach US$ 392.2 Mn by 2033 Says Persi …
The Libya baby diapers and wipes market is projected to expand at a 4.5% compound annual growth rate (CAGR) from 2023 to 2033, reaching an estimated value of US$ 392.2 million by 2033. The market was valued at US$ 242.9 million at the end of 2022.
Request a Sample: https://www.persistencemarketresearch.com/samples/33030
Key Market Drivers
Several factors are underpinning the growth in the Libyan market for baby diapers and wipes:
• Growing awareness of infant hygiene: As…
Foodservice Packaging Market Worth 522.4 Billion by 2032 - Persistence Market Re …
The foodservice packaging market is undergoing significant transformation, driven by evolving consumer preferences, technological innovations, and rising sustainability demands. Foodservice packaging encompasses a wide range of products including containers, trays, cups, lids, bags, and cutlery used across quick-service restaurants, full-service dining, catering, and delivery platforms.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/22354
As global food consumption habits shift toward convenience and on-the-go…
BOPP for Labels Market to Reach US$ 31.2 Billion by 2032 with 6.1% CAGR, Reports …
The packaging and labelling industry has witnessed significant transformation over the past decade, with brands increasingly seeking materials that are cost-effective, durable, and visually appealing. One material that has gained substantial traction in this context is biaxially oriented polypropylene, commonly known as BOPP. BOPP films are widely recognized for their versatility, excellent printability, and resilience against moisture and chemicals. These characteristics make BOPP an ideal choice for labels across various…
Emulsion Explosives Market to Grow from US$ 2.57 Billion in 2024 to US$ 3.57 Bil …
The global emulsion explosive market has witnessed substantial growth over the past few years, driven by increasing demand from the mining, construction, and infrastructure sectors. Emulsion explosives are considered a safer, more efficient alternative to traditional blasting agents due to their improved performance, water resistance, and enhanced safety profile. Their adoption is growing steadily as industries seek higher productivity, better control, and environmentally safer solutions for blasting operations.
Get a Sample…
More Releases for Psoriasis
Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual…
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
